BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Harnois DM, Steers J, Andrews JC, Rubin JC, Pitot HC, Burgart L, Wiesner RH, Gores GJ. Preoperative hepatic artery chemoembolization followed by orthotopic liver transplantation for hepatocellular carcinoma. Liver Transpl Surg. 1999;5:192-199. [PMID: 10226109 DOI: 10.1002/lt.500050307] [Cited by in Crossref: 95] [Cited by in F6Publishing: 90] [Article Influence: 4.1] [Reference Citation Analysis]
Number Citing Articles
1 Dharancy S, Boitard J, Decaens T, Sergent G, Boleslawski E, Duvoux C, Vanlemmens C, Meyer C, Gugenheim J, Durand F. Comparison of two techniques of transarterial chemoembolization before liver transplantation for hepatocellular carcinoma: a case-control study. Liver Transpl. 2007;13:665-671. [PMID: 17427172 DOI: 10.1002/lt.21109] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
2 Díaz-Sánchez A, Matilla A, Núñez O, Merino B, Peligros I, Rincón D, Salcedo M, Lo Iacono O, Vega Catalina M, Clemente G, Bañares R. [Influence of treatment of hepatocellular carcinoma before liver transplantation on post transplant tumor recurrence and survival]. Gastroenterol Hepatol 2010;33:155-64. [PMID: 19945770 DOI: 10.1016/j.gastrohep.2009.10.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
3 Fan ST, Cheung ST, Lo CM. Indications for liver transplantation in patients with chronic hepatitis B and C virus infection and hepatocellular carcinoma. J Gastroenterol Hepatol 2000;15 Suppl:E181-6. [PMID: 10921405 DOI: 10.1046/j.1440-1746.2000.02119.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
4 Helton WS, Di Bisceglie A, Chari R, Schwartz M, Bruix J. Treatment strategies for hepatocellular carcinoma in cirrhosis. J Gastrointest Surg 2003;7:401-11. [PMID: 12654567 DOI: 10.1016/s1091-255x(02)00161-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
5 Marelli L, Stigliano R, Triantos C, Senzolo M, Cholongitas E, Davies N, Yu D, Meyer T, Patch DW, Burroughs AK. Treatment outcomes for hepatocellular carcinoma using chemoembolization in combination with other therapies. Cancer Treat Rev 2006;32:594-606. [PMID: 17045407 DOI: 10.1016/j.ctrv.2006.08.002] [Cited by in Crossref: 65] [Cited by in F6Publishing: 62] [Article Influence: 4.1] [Reference Citation Analysis]
6 Strong RW. Transplantation for liver and biliary cancer. Semin Surg Oncol 2000;19:189-99. [DOI: 10.1002/1098-2388(200009)19:2<189::aid-ssu10>3.0.co;2-u] [Cited by in Crossref: 29] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
7 Lau WY, Yu SC, Lai EC, Leung TW. Transarterial chemoembolization for hepatocellular carcinoma. J Am Coll Surg. 2006;202:155-168. [PMID: 16377509 DOI: 10.1016/j.jamcollsurg.2005.06.263] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 3.1] [Reference Citation Analysis]
8 Lubienski A. Hepatocellular carcinoma: interventional bridging to liver transplantation. Transplantation. 2005;80:S113-S119. [PMID: 16286887 DOI: 10.1097/01.tp.0000187109.69663.93] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 2.1] [Reference Citation Analysis]
9 Machicao VI, Krishna M, Bonatti H, Aqel BA, Nguyen JH, Weigand SD, Rosser BG, Hughes C, Dickson RC. Hepatitis C recurrence is not associated with allograft steatosis within the first year after liver transplantation: Hepatitis C Recurrence after Liver Transplantation. Liver Transpl 2004;10:599-606. [DOI: 10.1002/lt.20107] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
10 Carlis L, Giacomoni A, Lauterio A, Slim A, Sammartino C, Pirotta V, Colella G, Forti D. Liver transplantation for hepatocellular cancer: should the current indication criteria be changed? Transplant Int 2003;16:115-22. [DOI: 10.1111/j.1432-2277.2003.tb00272.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 34] [Article Influence: 2.3] [Reference Citation Analysis]
11 Walser EM. Preoperative portal venous and hepatic arterial embolization of tumor. Semin Intervent Radiol 2008;25:242-51. [PMID: 21326514 DOI: 10.1055/s-0028-1085926] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
12 Hussain SA, Ferry DR, El-Gazzaz G, Mirza DF, James ND, McMaster P, Kerr DJ. Hepatocellular carcinoma. Ann Oncol. 2001;12:161-172. [PMID: 11300318 DOI: 10.1023/a:1008370324827] [Cited by in Crossref: 78] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
13 Maddala YK, Stadheim L, Andrews JC, Burgart LJ, Rosen CB, Kremers WK, Gores G. Drop-out rates of patients with hepatocellular cancer listed for liver transplantation: Outcome with chemoembolization: Drop-Out Rates for HCC. Liver Transpl 2004;10:449-55. [DOI: 10.1002/lt.20099] [Cited by in Crossref: 168] [Cited by in F6Publishing: 152] [Article Influence: 9.3] [Reference Citation Analysis]
14 Roayaie S, Llovet JM. Liver Transplantation for Hepatocellular Carcinoma: Is Expansion of Criteria Justified? Clinics in Liver Disease 2005;9:315-28. [DOI: 10.1016/j.cld.2004.12.007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
15 Machicao VI, Bonatti H, Krishna M, Aqel BA, Lukens FJ, Nguyen JH, Rosser BG, Satyanarayana R, Grewal HP, Hewitt WR, Harnois DM, Crook JE, Steers JL, Dickson RC. Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C. Transplantation 2004;77:84-92. [PMID: 14724440 DOI: 10.1097/01.TP.0000095896.07048.BB] [Cited by in Crossref: 126] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
16 Santoyo J, Suárez M, Fernández J, Jiménez M, Ramírez C, Pérez Daga A, Bondia J, de la Fuente A. Tratamiento quirúrgico del hepatocarcinoma en el paciente cirrótico: ¿resección o trasplante? Cirugía Española 2001;70:42-8. [DOI: 10.1016/s0009-739x(01)71839-8] [Cited by in Crossref: 5] [Article Influence: 0.2] [Reference Citation Analysis]
17 Rosen HR. DISEASE RECURRENCE FOLLOWING LIVER TRANSPLANTATION. Clinics in Liver Disease 2000;4:675-89. [DOI: 10.1016/s1089-3261(05)70132-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
18 Sun P, Chen C, Hsu S, Huang T, Chen T, Chen Y, Tsang L, Cheng Y. The significance of transarterial embolization for advanced hepatocellular carcinoma in liver transplantation. Transplantation Proceedings 2004;36:2295-6. [DOI: 10.1016/j.transproceed.2004.07.068] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
19 Bolondi L, Piscaglia F, Camaggi V, Grazi GL, Cavallari A. Review article: liver transplantation for HCC. Treatment options on the waiting list. Aliment Pharmacol Ther. 2003;17 Suppl 2:145-150. [PMID: 12786626 DOI: 10.1046/j.1365-2036.17.s2.8.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
20 Hanje AJ, Yao FY. Current approach to down-staging of hepatocellular carcinoma prior to liver transplantation. Curr Opin Organ Transplant 2008;13:234-40. [PMID: 18685309 DOI: 10.1097/MOT.0b013e3282fc2633] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
21 Decaens T, Hurtova M, Duvoux C. Transplantation hépatique pour carcinome hépatocellulaire. Gastroentérologie Clinique et Biologique 2009;33:61-9. [DOI: 10.1016/j.gcb.2008.11.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
22 Sato K, Lewandowski RJ, Bui JT, Omary R, Hunter RD, Kulik L, Mulcahy M, Liu D, Chrisman H, Resnick S. Treatment of unresectable primary and metastatic liver cancer with yttrium-90 microspheres (TheraSphere): assessment of hepatic arterial embolization. Cardiovasc Intervent Radiol. 2006;29:522-529. [PMID: 16729228 DOI: 10.1007/s00270-005-0171-4] [Cited by in Crossref: 158] [Cited by in F6Publishing: 156] [Article Influence: 9.9] [Reference Citation Analysis]
23 Malogolowkin MH, Stanley P, Steele DA, Ortega JA. Feasibility and Toxicity of Chemoembolization for Children With Liver Tumors. JCO 2000;18:1279-84. [DOI: 10.1200/jco.2000.18.6.1279] [Cited by in Crossref: 73] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
24 Lopez PM, Villanueva A, Roayaie S, Llovet JM. Neoadjuvant therapies for hepatocellular carcinoma before liver transplantation: a critical appraisal. Liver Transpl. 2006;12:1747-1754. [PMID: 17133591 DOI: 10.1002/lt.21018] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
25 Choi CS, Kim KH, Seo GS, Cho EY, Oh HJ, Choi SC, Kim TH, Kim HC, Roh BS. Cerebral and pulmonary embolisms after transcatheter arterial chemoembolization for hepatocellular carcinoma. World J Gastroenterol 2008; 14(30): 4834-4837 [PMID: 18720550 DOI: 10.3748/wjg.14.4834] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
26 Aloia TA, Adam R, Samuel D, Azoulay D, Castaing D. A decision analysis model identifies the interval of efficacy for transarterial chemoembolization (TACE) in cirrhotic patients with hepatocellular carcinoma awaiting liver transplantation. J Gastrointest Surg. 2007;11:1328-1332. [PMID: 17682827 DOI: 10.1007/s11605-007-0211-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
27 Jansen PL. Liver disease in the elderly. Best Pract Res Clin Gastroenterol. 2002;16:149-158. [PMID: 11977934 DOI: 10.1053/bega.2002.0271] [Cited by in Crossref: 46] [Cited by in F6Publishing: 34] [Article Influence: 2.3] [Reference Citation Analysis]
28 Parolin MB, Coelho JC, Matias JE, Puccinelli V, Jarabiza R, Ioshii SO. [Results of liver transplantation in patients with hepatocellular carcinoma]. Arq Gastroenterol 2001;38:216-20. [PMID: 12068530 DOI: 10.1590/s0004-28032001000400002] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Millonig G, Graziadei IW, Freund MC, Jaschke W, Stadlmann S, Ladurner R, Margreiter R, Vogel W. Response to preoperative chemoembolization correlates with outcome after liver transplantation in patients with hepatocellular carcinoma. Liver Transpl. 2007;13:272-279. [PMID: 17256758 DOI: 10.1002/lt.21033] [Cited by in Crossref: 183] [Cited by in F6Publishing: 156] [Article Influence: 12.2] [Reference Citation Analysis]
30 Marsh JW, Geller DA, Finkelstein SD, Donaldson JB, Dvorchik I. Role of liver transplantation for hepatobiliary malignant disorders. Lancet Oncol. 2004;5:480-488. [PMID: 15288237 DOI: 10.1016/S1470-2045(04)01527-X] [Cited by in Crossref: 19] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
31 Machicao VI, Srinivas TR, Hemming AW, Soldevila-Pico C, Firpi RJ, Reed AI, Morelli GJ, Nelson DR, Abdelmalek MF. Impact of implementation of the MELD scoring system on the prevalence and incidence of chronic renal disease following liver transplantation. Liver Transpl 2006;12:754-61. [PMID: 16528716 DOI: 10.1002/lt.20686] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 1.7] [Reference Citation Analysis]
32 Duller D Jr, Stiegler P, Schweiger M, Kahn J, Kniepeiss D, Jakoby E, Tscheliessnigg K, Iberer F. Sensitive serum parameters for hepatocellular carcinoma recurrence monitoring after liver transplantation: a case report. Transplant Proc 2007;39:3281-3. [PMID: 18089371 DOI: 10.1016/j.transproceed.2007.04.030] [Reference Citation Analysis]
33 Alba E, Valls C, Dominguez J, Martinez L, Escalante E, Lladó L, Serrano T. Transcatheter arterial chemoembolization in patients with hepatocellular carcinoma on the waiting list for orthotopic liver transplantation. AJR Am J Roentgenol. 2008;190:1341-1348. [PMID: 18430853 DOI: 10.2214/ajr.07.2972] [Cited by in Crossref: 50] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
34 Kothary N, Weintraub JL, Susman J, Rundback JH. Transarterial chemoembolization for primary hepatocellular carcinoma in patients at high risk. J Vasc Interv Radiol. 2007;18:1517-1526; quiz 1527. [PMID: 18057286 DOI: 10.1016/j.jvir.2007.07.035] [Cited by in Crossref: 63] [Cited by in F6Publishing: 71] [Article Influence: 4.5] [Reference Citation Analysis]
35 Yao FY, Kinkhabwala M, LaBerge JM, Bass NM, Brown R, Kerlan R, Venook A, Ascher NL, Emond JC, Roberts JP. The impact of pre-operative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinoma. Am J Transplant. 2005;5:795-804. [PMID: 15760404 DOI: 10.1111/j.1600-6143.2005.00750.x] [Cited by in Crossref: 140] [Cited by in F6Publishing: 121] [Article Influence: 8.2] [Reference Citation Analysis]
36 Molmenti EP, Klintmalm GB. Liver transplantation in association with hepatocellular carcinoma: an update of the International Tumor Registry. Liver Transpl. 2002;8:736-748. [PMID: 12200772 DOI: 10.1053/jlts.2002.34879] [Cited by in Crossref: 102] [Cited by in F6Publishing: 93] [Article Influence: 5.4] [Reference Citation Analysis]
37 Pommergaard HC, Rostved AA, Adam R, Thygesen LC, Salizzoni M, Gómez Bravo MA, Cherqui D, De Simone P, Boudjema K, Mazzaferro V, Soubrane O, García-Valdecasas JC, Fabregat Prous J, Pinna AD, O'Grady J, Karam V, Duvoux C, Rasmussen A; European Liver and Intestine Transplant Association (ELITA). Locoregional treatments before liver transplantation for hepatocellular carcinoma: a study from the European Liver Transplant Registry. Transpl Int 2018;31:531-9. [PMID: 29380442 DOI: 10.1111/tri.13123] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
38 Lesurtel M, Müllhaupt B, Pestalozzi BC, Pfammatter T, Clavien PA. Transarterial chemoembolization as a bridge to liver transplantation for hepatocellular carcinoma: an evidence-based analysis. Am J Transplant. 2006;6:2644-2650. [PMID: 16939518 DOI: 10.1111/j.1600-6143.2006.01509.x] [Cited by in Crossref: 125] [Cited by in F6Publishing: 105] [Article Influence: 7.8] [Reference Citation Analysis]
39 Harnois DM. Hepatitis C virus infection and the rising incidence of hepatocellular carcinoma. Mayo Clin Proc. 2012;87:7-8. [PMID: 22212962 DOI: 10.1016/j.mayocp.2011.11.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
40 Wiesner RH, Rakela J, Ishitani MB, Mulligan DC, Spivey JR, Steers JL, Krom RA. Recent advances in liver transplantation. Mayo Clin Proc. 2003;78:197-210. [PMID: 12583530 DOI: 10.4065/78.2.197] [Cited by in Crossref: 69] [Cited by in F6Publishing: 48] [Article Influence: 3.6] [Reference Citation Analysis]
41 Tan K. Surgery for hepatocellular carcinoma: Surgery for HCC. Journal of Gastroenterology and Hepatology 2002;17:S421-3. [DOI: 10.1046/j.1440-1746.17.s3.38.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
42 She WH, Cheung TT. Bridging and downstaging therapy in patients suffering from hepatocellular carcinoma waiting on the list of liver transplantation. Transl Gastroenterol Hepatol. 2016;1:34. [PMID: 28138601 DOI: 10.21037/tgh.2016.03.04] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
43 Oligane HC, Close ON, Xing M, Kim HS. Bridging locoregional therapy: Longitudinal trends and outcomes in patients with hepatocellular carcinoma. Transplant Rev (Orlando) 2017;31:136-43. [PMID: 28214240 DOI: 10.1016/j.trre.2017.01.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
44 Li HL, Ji WB, Zhao R, Duan WD, Chen YW, Wang XQ, Yu Q, Luo Y, Dong JH. Poor prognosis for hepatocellular carcinoma with transarterial chemoembolization pre-transplantation: Retrospective analysis. World J Gastroenterol 2015; 21(12): 3599-3606 [PMID: 25834326 DOI: 10.3748/wjg.v21.i12.3599] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
45 Kuyvenhoven JPh CB, van Hoek B. Practical management of hepatocellular carcinoma. Scand J Gastroenterol Suppl. 2001;234:82-87. [PMID: 11768566 DOI: 10.1080/003655201753265154] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
46 Mostafa EM, Ganguli S, Faintuch S, Mertyna P, Goldberg SN. Optimal strategies for combining transcatheter arterial chemoembolization and radiofrequency ablation in rabbit VX2 hepatic tumors. J Vasc Interv Radiol 2008;19:1740-8. [PMID: 18951042 DOI: 10.1016/j.jvir.2008.08.028] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 2.4] [Reference Citation Analysis]
47 Azzam AZ. Liver transplantation as a management of hepatocellular carcinoma. World J Hepatol 2015; 7(10): 1347-1354 [PMID: 26052380 DOI: 10.4254/wjh.v7.i10.1347] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
48 Kiely JM, Rilling WS, Touzios JG, Hieb RA, Franco J, Saeian K, Quebbeman EJ, Pitt HA. Chemoembolization in Patients at High Risk: Results and Complications. Journal of Vascular and Interventional Radiology 2006;17:47-53. [DOI: 10.1097/01.rvi.0000195074.43474.2f] [Cited by in Crossref: 37] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
49 Stadlbauer V, Schaffellner S, Kniepeiss D, Jakoby E, Stauber R, Iberer F, Tscheliessnigg KH. Experiences in liver transplantation for hepatocellular carcinoma. Transplant Proc 2004;36:195-8. [PMID: 15013344 DOI: 10.1016/j.transproceed.2003.11.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
50 Befeler AS, Di Bisceglie AM. Hepatocellular carcinoma: diagnosis and treatment. Gastroenterology. 2002;122:1609-1619. [PMID: 12016426 DOI: 10.1053/gast.2002.33411] [Cited by in Crossref: 374] [Cited by in F6Publishing: 363] [Article Influence: 18.7] [Reference Citation Analysis]
51 Mela M, Mancuso A, Burroughs AK. Review article: hepatocellular carcinoma: indications for liver transplantation. Aliment Pharmacol Ther. 2003;17 Suppl 2:130-137. [PMID: 12786624 DOI: 10.1046/j.1365-2036.17.s2.16.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 0.7] [Reference Citation Analysis]
52 Souto E, Gores GJ. When should a liver mass suspected of being a hepatocellular carcinoma be biopsied? Liver Transpl. 2000;6:73-75. [PMID: 10648581 DOI: 10.1002/lt.500060108] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
53 Kulik LM, Atassi B, van Holsbeeck L, Souman T, Lewandowski RJ, Mulcahy MF, Hunter RD, Nemcek AA, Abecassis MM, Haines KG, Salem R. Yttrium-90 microspheres (TheraSphere) treatment of unresectable hepatocellular carcinoma: Downstaging to resection, RFA and bridge to transplantation. J Surg Oncol. 2006;94:572-586. [PMID: 17048240 DOI: 10.1002/jso.20609] [Cited by in Crossref: 227] [Cited by in F6Publishing: 199] [Article Influence: 14.2] [Reference Citation Analysis]
54 Ahrar K, Gupta S. Hepatic artery embolization for hepatocellular carcinoma: technique, patient selection, and outcomes. Surg Oncol Clin N Am. 2003;12:105-126. [PMID: 12735133 DOI: 10.1016/s1055-3207(02)00089-3] [Cited by in Crossref: 28] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
55 Vasuri F, Malvi D, Rosini F, Baldin P, Fiorentino M, Paccapelo A, Ercolani G, Pinna AD, Golfieri R, Morselli-Labate AM, Grigioni WF, D’Errico-Grigioni A. Revisiting the role of pathological analysis in transarterial chemoembolization-treated hepatocellular carcinoma after transplantation. World J Gastroenterol 2014; 20(37): 13538-13545 [PMID: 25309084 DOI: 10.3748/wjg.v20.i37.13538] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
56 Ho M, Yu C, Chung K, Chen T, Chu H, Lin C, Hsieh C. Locoregional Therapy-Induced Tumor Necrosis as a Predictor of Recurrence after Liver Transplant in Patients with Hepatocellular Carcinoma. Ann Surg Oncol 2011;18:3632-9. [DOI: 10.1245/s10434-011-1803-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
57 Palmer WC, Lee D, Burns J, Croome K, Rosser B, Patel T, Keaveny AP, Pungpapong S, Satyanarayana R, Yataco M, Nakhleh R, Musto KR, Canabal AM, Turnage AK, Hodge DO, Nguyen JH, Harnois DM. Liver Transplantation for Hepatocellular Carcinoma: Impact of Wait Time at a Single Center. Annals of Hepatology 2017;16:402-11. [DOI: 10.5604/01.3001.0009.8595] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
58 De Carlis L, Giacomoni A, Pirotta V, Lauterio A, Slim AO, Sammartino C, Cardillo M, Forti D. Surgical treatment of hepatocellular cancer in the era of hepatic transplantation. Journal of the American College of Surgeons 2003;196:887-97. [DOI: 10.1016/s1072-7515(03)00140-6] [Cited by in Crossref: 60] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
59 Llovet JM, Mas X, Aponte JJ, Fuster J, Navasa M, Christensen E, Rodés J, Bruix J. Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation. Gut. 2002;50:123-128. [PMID: 11772979 DOI: 10.1136/gut.50.1.123] [Cited by in Crossref: 202] [Cited by in F6Publishing: 178] [Article Influence: 10.1] [Reference Citation Analysis]
60 Aguayo A, Patt YZ. Nonsurgical Treatment of Hepatocellular Carcinoma. Clinics in Liver Disease 2001;5:175-89. [DOI: 10.1016/s1089-3261(05)70160-4] [Cited by in Crossref: 5] [Article Influence: 0.2] [Reference Citation Analysis]
61 Ghabril M, Dickson RC, Machicao VI, Aranda-Michel J, Keaveny A, Rosser B, Bonatti H, Krishna M, Yataco M, Satyanarayana R, Harnois D, Hewitt W, Willingham DD, Grewal H, Hughes CB, Nguyen J. Liver retransplantation of patients with hepatitis C infection is associated with acceptable patient and graft survival. Liver Transpl 2007;13:1717-27. [PMID: 18044750 DOI: 10.1002/lt.21292] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
62 Rust C, Gores GJ. Locoregional management of hepatocellular carcinoma. Surgical and ablation therapies. Clin Liver Dis. 2001;5:161-173. [PMID: 11218913 DOI: 10.1016/s1089-3261(05)70159-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
63 Llovet JM, Bruix J, Gores GJ. Surgical resection versus transplantation for early hepatocellular carcinoma: clues for the best strategy. Hepatology 2000;31:1019-21. [DOI: 10.1053/he.2000.6959] [Cited by in Crossref: 137] [Cited by in F6Publishing: 136] [Article Influence: 6.2] [Reference Citation Analysis]
64 Wong LL. Current status of liver transplantation for hepatocellular cancer. Am J Surg. 2002;183:309-316. [PMID: 11943133 DOI: 10.1016/s0002-9610(02)00785-7] [Cited by in Crossref: 39] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
65 Garrean S, Hering J, Helton WS, Espat NJ. A primer on transarterial, chemical, and thermal ablative therapies for hepatic tumors. Am J Surg 2007;194:79-88. [PMID: 17560915 DOI: 10.1016/j.amjsurg.2006.11.025] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
66 Otto G, Herber S, Heise M, Lohse AW, Mönch C, Bittinger F, Hoppe-lotichius M, Schuchmann M, Victor A, Pitton M. Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma. Liver Transpl 2006;12:1260-7. [DOI: 10.1002/lt.20837] [Cited by in Crossref: 298] [Cited by in F6Publishing: 256] [Article Influence: 18.6] [Reference Citation Analysis]
67 Befeler AS, Hayashi PH, Di Bisceglie AM. Liver transplantation for hepatocellular carcinoma. Gastroenterology. 2005;128:1752-1764. [PMID: 15887162 DOI: 10.1053/j.gastro.2005.03.033] [Cited by in Crossref: 93] [Cited by in F6Publishing: 86] [Article Influence: 5.5] [Reference Citation Analysis]
68 Molmenti EP, Klintmalm GB. Cancer and liver transplantation. Transplantation Reviews 2000;14:183-98. [DOI: 10.1053/trre.2000.16513] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
69 Stockland AH, Walser EM, Paz-fumagalli R, Mckinney JM, May GR. Preoperative Chemoembolization in Patients with Hepatocellular Carcinoma Undergoing Liver Transplantation: Influence of Emergent Versus Elective Procedures on Patient Survival and Tumor Recurrence Rate. Cardiovasc Intervent Radiol 2007;30:888-93. [DOI: 10.1007/s00270-007-9111-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
70 De Carlis L, Di Sandro S, Giacomoni A, Slim A, Lauterio A, Mangoni I, Mihaylov P, Pirotta V, Aseni P, Rampoldi A. Beyond the Milan criteria: what risks for patients with hepatocellular carcinoma progression before liver transplantation? J Clin Gastroenterol. 2012;46:78-86. [PMID: 21897282 DOI: 10.1097/mcg.0b013e31822b36f6] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
71 Pérez Saborido B, Meneu JC, Moreno E, García I, Moreno A, Fundora Y. Is transarterial chemoembolization necessary before liver transplantation for hepatocellular carcinoma? Am J Surg. 2005;190:383-387. [PMID: 16105523 DOI: 10.1016/j.amjsurg.2005.06.001] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 2.1] [Reference Citation Analysis]
72 Brillet PY, Paradis V, Brancatelli G, Rangheard AS, Consigny Y, Plessier A, Durand F, Belghiti J, Sommacale D, Vilgrain V. Percutaneous radiofrequency ablation for hepatocellular carcinoma before liver transplantation: a prospective study with histopathologic comparison. AJR Am J Roentgenol. 2006;186:S296-S305. [PMID: 16632691 DOI: 10.2214/ajr.04.1927] [Cited by in Crossref: 46] [Cited by in F6Publishing: 18] [Article Influence: 3.1] [Reference Citation Analysis]
73 Graziadei IW, Sandmueller H, Waldenberger P, Koenigsrainer A, Nachbaur K, Jaschke W, Margreiter R, Vogel W. Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome. Liver Transpl. 2003;9:557-563. [PMID: 12783395 DOI: 10.1053/jlts.2003.50106] [Cited by in Crossref: 328] [Cited by in F6Publishing: 299] [Article Influence: 17.3] [Reference Citation Analysis]
74 Befeler AS. Chemoembolization and bland embolization: a critical appraisal. Clin Liver Dis 2005;9:287-300, vii. [PMID: 15831274 DOI: 10.1016/j.cld.2004.12.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
75 Oligane HC, Xing M, Kim HS. Effect of Bridging Local-Regional Therapy on Recurrence of Hepatocellular Carcinoma and Survival after Orthotopic Liver Transplantation. Radiology 2017;282:869-79. [DOI: 10.1148/radiol.2016160288] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
76 Dickson RC, Pungpapong S, Keaveny AP, Taner CB, Ghabril M, Aranda-michel J, Satyanarayana R, Bonatti H, Kramer DJ, Nguyen JH. Improving graft survival for patients undergoing liver transplantation: Improving graft survival. Clinical Transplantation 2011;25:E345-55. [DOI: 10.1111/j.1399-0012.2011.01428.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
77 Jang JW, Choi JY, Bae SH, Kim CW, Cho SH, Yoon SK, Yang JM, Han JY, Lee YS, Kim DG. The best candidates for transarterial chemotherapy in patients with hepatocellular carcinoma awaiting liver transplantation: a cohort-based characterization of dropout times: BEST CANDIDATES FOR PRE-TRANSPLANT TRANSARTERIAL THERAPY IN HCC. Alimentary Pharmacology & Therapeutics 2007;26:87-94. [DOI: 10.1111/j.1365-2036.2007.03345.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
78 Bharat A, Brown DB, Crippin JS, Gould JE, Lowell JA, Shenoy S, Desai NM, Chapman WC. Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival. J Am Coll Surg. 2006;203:411-420. [PMID: 17000383 DOI: 10.1016/j.jamcollsurg.2006.06.016] [Cited by in Crossref: 92] [Cited by in F6Publishing: 82] [Article Influence: 5.8] [Reference Citation Analysis]
79 Fisher RA, Maroney TP, Fulcher AS, Maluf D, Clay JA, Wolfe LG, Dawson S 3rd, Cotterell A, Stravitz RT, Luketic VA, Shiffman M, Sterling RK, Posner MP. Hepatocellular carcinoma: strategy for optimizing surgical resection, transplantation and palliation. Clin Transplant 2002;16 Suppl 7:52-8. [PMID: 12372045 DOI: 10.1034/j.1399-0012.16.s7.8.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
80 Rilling WS, Hohenwalter EJ. Combining local and regional therapeutic modalities to treat hepatic malignancies. Semin Intervent Radiol 2006;23:33-8. [PMID: 21326718 DOI: 10.1055/s-2006-939839] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
81 Minici R, Ammendola M, Manti F, Siciliano MA, Giglio E, Minici M, Melina M, Currò G, Laganà D. Safety and Efficacy of Degradable Starch Microspheres Transcatheter Arterial Chemoembolization as a Bridging Therapy in Patients with Early Stage Hepatocellular Carcinoma and Child-Pugh Stage B Eligible for Liver Transplant. Front Pharmacol 2021;12:634084. [PMID: 33897421 DOI: 10.3389/fphar.2021.634084] [Reference Citation Analysis]
82 Decaens T, Roudot-Thoraval F, Bresson-Hadni S, Meyer C, Gugenheim J, Durand F, Bernard PH, Boillot O, Boudjema K, Calmus Y, Hardwigsen J, Ducerf C, Pageaux GP, Dharancy S, Chazouilleres O, Dhumeaux D, Cherqui D, Duvoux C. Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma. Liver Transpl. 2005;11:767-775. [PMID: 15973710 DOI: 10.1002/lt.20418] [Cited by in Crossref: 160] [Cited by in F6Publishing: 142] [Article Influence: 9.4] [Reference Citation Analysis]
83 Saggi BH, Farmer DG, Yersiz H, Busuttil RW. Surgical advances in liver and bowel transplantation. Anesthesiol Clin North Am 2004;22:713-40. [PMID: 15541932 DOI: 10.1016/j.atc.2004.07.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
84 Andriulli A, de Sio I, Solmi L, De Carlis L, Troisi R, Grasso A, Festa V, Caturelli E, Giacomoni A, Del Vecchio Blanco C, De Hemptinne B, Burroughs A, Perri F. Survival of cirrhotic patients with early hepatocellular carcinoma treated by percutaneous ethanol injection or liver transplantation. Liver Transpl 2004;10:1355-63. [DOI: 10.1002/lt.20251] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
85 Pérez-Saborido B, de los Galanes SJ, Menéu-Díaz JC, Romero CJ, Elola-Olaso AM, Suárez YF, Valencia VB, Moreno-González E. Tumor recurrence after liver transplantation for hepatocellular carcinoma: recurrence pathway and prognostic factors. Transplant Proc. 2007;39:2304-2307. [PMID: 17889172 DOI: 10.1016/j.transproceed.2007.06.059] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 2.5] [Reference Citation Analysis]
86 Otto G. Reply: selection criteria for liver transplantation in patients with hepatocellular carcinoma: beyond tumor size and number? Liver Transpl 2007;13:470-1. [PMID: 17318868 DOI: 10.1002/lt.21048] [Reference Citation Analysis]
87 Burak KW, Kremers WK, Batts KP, Wiesner RH, Rosen CB, Razonable RR, Paya CV, Charlton MR. Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C. Liver Transpl. 2002;8:362-369. [PMID: 11965581 DOI: 10.1053/jlts.2002.32282] [Cited by in Crossref: 193] [Cited by in F6Publishing: 169] [Article Influence: 9.7] [Reference Citation Analysis]
88 Rilling WS, Drooz A. Multidisciplinary Management of Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology 2002;13:S259-63. [DOI: 10.1016/s1051-0443(07)61794-1] [Cited by in Crossref: 31] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
89 Koschny R, Schmidt J, Ganten TM. Beyond Milan criteria--chances and risks of expanding transplantation criteria for HCC patients with liver cirrhosis. Clin Transplant 2009;23 Suppl 21:49-60. [PMID: 19930317 DOI: 10.1111/j.1399-0012.2009.01110.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
90 Habibollahi P, Hunt S, Gade T, Dagli MS, Mondschein JI, Sudheendra D, Stavropoulos SW, Soulen M, Gregory N. The Impact of Bridging LRT on Survival in Patients Listed for Liver Transplantation. Cardiovasc Intervent Radiol 2018;41:112-9. [DOI: 10.1007/s00270-017-1759-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
91 Gores G. Hepatocellular carcinoma: Gardening strategies and bridges to transplantation. Liver Transplantation 2003;9:199-200. [DOI: 10.1053/jlts.2003.0090199] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]